Antigen-specific immune effector cells immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antigen-specific immune effector cells immunotherapy, covering 2020-06-12 to 2020-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis [Phase 1, Phase 2]